Atripla and Valacyclovir hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate) and Valacyclovir hydrochloride (valacyclovir hydrochloride). Common drug interactions include joint swelling among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Atripla and Valacyclovir hydrochloride. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.



On Jul, 09, 2026

54 people who take Atripla and Valacyclovir hydrochloride together, and have interactions are studied.

Atripla and Valacyclovir hydrochloride drug interactions.

What are the common drug interactions of Atripla and Valacyclovir Hydrochloride, by gender? *:

female:

  1. Joint swelling
  2. Skeletal injury (bone and supporting muscle injury)
  3. Chronic kidney disease
  4. Mobility decreased (ability to move is reduced)
  5. Renal failure (kidney dysfunction)
  6. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  7. Arthropathy
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Anaemia (lack of blood)
  10. Ankle fracture

male:

  1. Anxiety
  2. Pain
  3. Foot fracture
  4. Hypertension (high blood pressure)
  5. Blood creatinine increased
  6. Mobility decreased (ability to move is reduced)
  7. Quality of life decreased
  8. Bone density decreased
  9. Osteomalacia (softening of the bones due to a lack of vitamin d)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Atripla and Valacyclovir Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Glomerulosclerosis (a hardening of the glomerulus in the kidney)
  6. Hypertension (high blood pressure)
  7. Immune system disorder
  8. Mobility decreased (ability to move is reduced)
  9. Pain
  10. Renal impairment (severely reduced kidney function)

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Hypertension (high blood pressure)
  7. Renal failure (kidney dysfunction)
  8. Anaemia (lack of blood)
  9. Blood creatinine increased
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

40-49:

  1. Foot fracture
  2. Decreased activity
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Osteomalacia (softening of the bones due to a lack of vitamin d)
  7. Bone disorder
  8. Impaired work ability
  9. Bone density decreased
  10. Gait disturbance

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Multiple fractures
  8. Back pain
  9. Gait disturbance
  10. Joint range of motion decreased (disease of joint movement)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthropathy
  4. Fear
  5. Mobility decreased (ability to move is reduced)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  8. Chronic kidney disease
  9. Foot fracture
  10. Ankle fracture

What are the existing conditions these people have? *

  1. Pain: 5 people, 9.26%
  2. High Blood Pressure: 4 people, 7.41%
  3. Viral Infection: 3 people, 5.56%
  4. Fungal Infection: 3 people, 5.56%
  5. Erection Problems: 3 people, 5.56%
  6. Bacterial Infection: 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and Valacyclovir hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atripla and Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atripla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate and valacyclovir hydrochloride (the active ingredients of Atripla and Valacyclovir hydrochloride, respectively), and Atripla and Valacyclovir hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: